South Korea · Delayed Price · Currency is KRW ALTEOGEN Statistics
Total Valuation
ALTEOGEN has a market cap or net worth of KRW 22.55 trillion. The enterprise value is 22.30 trillion.
| Market Cap | 22.55T |
| Enterprise Value | 22.30T |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALTEOGEN has 53.44 million shares outstanding. The number of shares has increased by 10.70% in one year.
| Current Share Class | 53.44M |
| Shares Outstanding | 53.44M |
| Shares Change (YoY) | +10.70% |
| Shares Change (QoQ) | -27.61% |
| Owned by Insiders (%) | 25.82% |
| Owned by Institutions (%) | 8.50% |
| Float | 39.59M |
Valuation Ratios
The trailing PE ratio is 260.92 and the forward PE ratio is 217.92.
| PE Ratio | 260.92 |
| Forward PE | 217.92 |
| PS Ratio | 142.68 |
| PB Ratio | 48.37 |
| P/TBV Ratio | 66.11 |
| P/FCF Ratio | 274.95 |
| P/OCF Ratio | 260.62 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 284.74, with an EV/FCF ratio of 271.82.
| EV / Earnings | 236.46 |
| EV / Sales | 141.06 |
| EV / EBITDA | 284.74 |
| EV / EBIT | 295.50 |
| EV / FCF | 271.82 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.12 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.09 |
| Interest Coverage | 15.73 |
Financial Efficiency
Return on equity (ROE) is 24.77% and return on invested capital (ROIC) is 12.42%.
| Return on Equity (ROE) | 24.77% |
| Return on Assets (ROA) | 10.38% |
| Return on Invested Capital (ROIC) | 12.42% |
| Return on Capital Employed (ROCE) | 15.99% |
| Revenue Per Employee | 1.02B |
| Profits Per Employee | 608.31M |
| Employee Count | 155 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 30.71 |
Taxes
| Income Tax | -9.70B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.27% in the last 52 weeks. The beta is 1.15, so ALTEOGEN's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +46.27% |
| 50-Day Moving Average | 427,670.00 |
| 200-Day Moving Average | 373,662.50 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 316,583 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ALTEOGEN had revenue of KRW 158.06 billion and earned 94.29 billion in profits. Earnings per share was 1,617.35.
| Revenue | 158.06B |
| Gross Profit | 118.30B |
| Operating Income | 75.46B |
| Pretax Income | 82.00B |
| Net Income | 94.29B |
| EBITDA | 78.31B |
| EBIT | 75.46B |
| Earnings Per Share (EPS) | 1,617.35 |
Balance Sheet
The company has 386.66 billion in cash and 7.14 billion in debt, giving a net cash position of 379.52 billion or 7,101.60 per share.
| Cash & Cash Equivalents | 386.66B |
| Total Debt | 7.14B |
| Net Cash | 379.52B |
| Net Cash Per Share | 7,101.60 |
| Equity (Book Value) | 466.20B |
| Book Value Per Share | 6,427.51 |
| Working Capital | 277.14B |
Cash Flow
In the last 12 months, operating cash flow was 86.53 billion and capital expenditures -4.51 billion, giving a free cash flow of 82.02 billion.
| Operating Cash Flow | 86.53B |
| Capital Expenditures | -4.51B |
| Free Cash Flow | 82.02B |
| FCF Per Share | 1,534.84 |
Margins
Gross margin is 74.85%, with operating and profit margins of 47.74% and 59.65%.
| Gross Margin | 74.85% |
| Operating Margin | 47.74% |
| Pretax Margin | 51.88% |
| Profit Margin | 59.65% |
| EBITDA Margin | 49.55% |
| EBIT Margin | 47.74% |
| FCF Margin | 51.89% |
Dividends & Yields
ALTEOGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.70% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.42% |
| FCF Yield | 0.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 25, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 25, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
ALTEOGEN has an Altman Z-Score of 81.99 and a Piotroski F-Score of 6.
| Altman Z-Score | 81.99 |
| Piotroski F-Score | 6 |